Skip to main content
eScholarship
Open Access Publications from the University of California

Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2

  • Author(s): Monk, BJ
  • Poveda, A
  • Vergote, I
  • Raspagliesi, F
  • Fujiwara, K
  • Bae, D-S
  • Oaknin, A
  • Ray-Coquard, I
  • Provencher, DM
  • Karlan, BY
  • Lhomme, C
  • Richardson, G
  • Rincon, DG
  • Coleman, RL
  • Marth, C
  • Brize, A
  • Fabbro, M
  • Redondo, A
  • Bamias, A
  • Ma, H
  • Vogl, FD
  • Bach, BA
  • Oza, AM
  • et al.
Item not freely available? Link broken?
Report a problem accessing this item